NIM
NEOS Investment Management Portfolio holdings
AUM
$8.08B
This Quarter Return
-3.62%
1 Year Return
+24.46%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$5.27B
AUM Growth
+$5.27B
(+24%)
Cap. Flow
+$1.26B
Cap. Flow
% of AUM
23.91%
Top 10 Holdings %
Top 10 Hldgs %
33.76%
Holding
622
New
34
Increased
509
Reduced
34
Closed
25
Top Buys
| 1 |
Apple
AAPL
|
$84.1M |
| 2 |
Microsoft
MSFT
|
$71.2M |
| 3 |
NVIDIA
NVDA
|
$67.2M |
| 4 |
Amazon
AMZN
|
$49.1M |
| 5 |
Meta Platforms (Facebook)
META
|
$31.8M |
Top Sells
| 1 |
Primoris Services
PRIM
|
$7.16M |
| 2 |
Fluor
FLR
|
$5.32M |
| 3 |
Federal Signal
FSS
|
$5.11M |
| 4 |
Allegion
ALLE
|
$3.66M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$2.66M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 10.37% |
| 3 | Communication Services | 9.8% |
| 4 | Consumer Discretionary | 9.65% |
| 5 | Financials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
Relay Therapeutics
RLAY
$709M
| $233K | ﹤0.01% |
89,110
+24,455
| +38% | +$64.1K |
|
577
Omega Healthcare
OHI
$12.5B
| $231K | ﹤0.01% |
+6,075
| New | +$231K |
|
578
Oric Pharmaceuticals
ORIC
$1.03B
| $228K | ﹤0.01% |
40,934
-4,542
| -10% | -$25.3K |
|
579
Labcorp
LH
$22.8B
| $225K | ﹤0.01% |
967
+1
| +0.1% | +$233 |
|
580
Domino's
DPZ
$15.8B
| $222K | ﹤0.01% |
484
| – | – |
|
581
F5
FFIV
$17.8B
| $220K | ﹤0.01% |
827
| – | – |
|
582
Everest Group
EG
$14.6B
| $218K | ﹤0.01% |
601
| – | – |
|
583
Lamar Advertising Co
LAMR
$12.8B
| $216K | ﹤0.01% |
+1,895
| New | +$216K |
|
584
Jazz Pharmaceuticals
JAZZ
$7.99B
| $208K | ﹤0.01% |
1,672
| – | – |
|
585
Denali Therapeutics
DNLI
$2.24B
| $206K | ﹤0.01% |
+15,174
| New | +$206K |
|
586
CubeSmart
CUBE
$9.31B
| $206K | ﹤0.01% |
+4,886
| New | +$206K |
|
587
Xenon Pharmaceuticals
XENE
$2.99B
| $205K | ﹤0.01% |
6,111
| – | – |
|
588
Ferrari
RACE
$88.2B
| $201K | ﹤0.01% |
+469
| New | +$201K |
|
589
Intellia Therapeutics
NTLA
$1.26B
| $189K | ﹤0.01% |
26,537
-101,289
| -79% | -$720K |
|
590
AGNC Investment
AGNC
$10.4B
| $185K | ﹤0.01% |
+19,340
| New | +$185K |
|
591
Acadia Pharmaceuticals
ACAD
$4.34B
| $176K | ﹤0.01% |
10,596
| – | – |
|
|
AUTL
592
Autolus Therapeutics
AUTL
$383M
| $171K | ﹤0.01% |
+110,428
| New | +$171K |
|
593
Celcuity
CELC
$2.3B
| $158K | ﹤0.01% |
+15,619
| New | +$158K |
|
594
Rithm Capital
RITM
$6.55B
| $128K | ﹤0.01% |
+11,190
| New | +$128K |
|
595
Arcus Biosciences
RCUS
$1.24B
| $120K | ﹤0.01% |
15,251
-6,982
| -31% | -$54.8K |
|
596
Talkspace
TALK
$444M
| $71.3K | ﹤0.01% |
27,834
+1,497
| +6% | +$3.83K |
|
597
Voyager Therapeutics
VYGR
$204M
| $50.6K | ﹤0.01% |
14,960
| – | – |
|
598
Advanced Energy
AEIS
$5.48B
| – | – |
-3,780
| Closed | -$437K |
|
599
Agios Pharmaceuticals
AGIO
$2.36B
| – | – |
-25,735
| Closed | -$846K |
|
600
Argan
AGX
$3.1B
| – | – |
-1,920
| Closed | -$263K |
|